BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8878597)

  • 1. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
    Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
    Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice.
    Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1999 Mar; 43(3):367-71. PubMed ID: 10223592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of penicillin alone and combined with gentamicin against clinical isolates of Streptococcus pneumoniae with decreased susceptibility to penicillin.
    Anadiotis L; Maskell JP; Sefton AM
    Int J Antimicrob Agents; 2002 Mar; 19(3):173-81. PubMed ID: 11932138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
    Ponte C; Parra A; Nieto E; Soriano F
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
    Abgueguen P; Azoulay-Dupuis E; Noel V; Moine P; Rieux V; Fantin B; Bedos JP
    Antimicrob Agents Chemother; 2007 Jan; 51(1):208-14. PubMed ID: 17060515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Choice of antibiotics in lower respiratory infections: what does pharmacodynamics bring? Data of experimental models].
    Bedos JP
    Presse Med; 1998 Sep; 27 Suppl 4():19-20. PubMed ID: 9798481
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.
    Moine P; Mazoit JX; Bédos JP; Vallée E; Azoulay-Dupuis E
    J Pharmacol Exp Ther; 1997 Jan; 280(1):310-5. PubMed ID: 8996211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between beta-lactam antibiotics and gentamicin against Streptococcus pneumoniae in vitro and in vivo.
    Frimodt-Møller N; Frølund Thomsen V
    Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):269-75. PubMed ID: 3673584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Mohler J; Bédos JP
    Antimicrob Agents Chemother; 2004 Jan; 48(1):80-5. PubMed ID: 14693522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
    Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.